NCF1 and Parkinson disease: After simvastatin treatment, the translocation of p47 phox and expression of gp91 phox was decreased in SH-SY5Y cells and PD mice, which suggests that simvastatin may down-regulate the activity of NADPH oxidase in the PD model, and reduce the formation of oxidative stress factor, to protect against the development of PD.